Delivery Order SPE2DE24D0013-SPE2D625F2YHF
- Not listed
- The U.S. Defense Medical Supply Chain awarded a $13.6K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 2, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order (Contract No. 4569302261) procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a continuation of...
- This delivery order, issued on July 28, 2025, awards Cepheid Inc. a firm fixed-price contract valued at $1,190.28 for molecular diagnostic solutions under a Defense Logistics Agency Medical Supply Chain program. The contract is set to be completed by August 11, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. The award reflects the company's established role as a key supplier of diagnostic systems and reagents to federal defense and healthcare agencies,...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- The Defense Logistics Agency awarded a $12,240 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, with an ultimate completion date of August 15, 2025, was awarded on August 8, 2025, with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits, will perform the work at its California...
- This delivery order, awarded July 28, 2025, represents a $3,400 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain division and Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California. The order is designated for respiratory pathogen testing, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance to be completed by August 4, 2025. No set-aside designation was applied to this procurement....
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded Cepheid Inc. a delivery order valued at $22,240 on September 9, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit...
- The Defense Logistics Agency's Medical Supply Chain has awarded a $7,904 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, represents procurement of diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract was awarded on September 8, 2025, with an ultimate completion date of September 15, 2025, and carries no...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,835 firm fixed-price delivery order to Cepheid Inc. on August 29, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which extends through September 8, 2025, will be performed at Cepheid's facility in Sunnyvale, California. This award carries no small business set-aside designation and represents a continuation of...
- The U.S. Department of Defense awarded a $2,040 firm fixed-price delivery order to Cepheid Inc. on August 5, 2025, under contract number 4569009257 for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus testing. The contract, which carries no set-aside designation, is set to conclude by August 12, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order falls under one of Cepheid's two significant...
- This delivery order, valued at $6,800, was awarded to Cepheid Inc. on September 4, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract covers molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance to be completed at Cepheid's Sunnyvale, California facility by September 11, 2025. The award carries a firm fixed-price structure with no set-aside designation, indicating competitive procurement....
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2YHFDelivery Order
This delivery order, awarded on September 9, 2025, represents a $41,490 firm fixed-price contract between the Defense Logistics Agency (Medical Supply Chain) and Cepheid Inc. for molecular diagnostic solutions. The contract, which runs through September 16, 2025, procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic systems, specializes in advanced infectious disease testing platforms and reagents that support federal healthcare systems. The award carries no set-aside designation, indicating open competition for the requirement. This delivery order likely derives from one of Cepheid's existing Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with the Department of Veterans Affairs, most notably a $32.8 million single-award IDIQ with VA's Veterans Integrated Service Network 6 that extends through September 2030 and covers molecular diagnostic testing system reagents and assays. Cepheid's established track record delivering diagnostic solutions across multiple VA networks, the Defense Health Agency, and the Indian Health Service positions the company as a key supplier for federal molecular diagnostics. The firm fixed-price structure and specific focus on respiratory pathogen detection reflect the ongoing federal demand for accessible, rapid diagnostic capabilities across defense and veteran healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.5k | 9/9/25 |